Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies by risk of exposure in a community health system.

Fletcher, Jeffrey J; Feucht, Eric C; Hahn, Peter Y; McGoff, Theresa N; Dehart, Del J; Mortada, Mohamad E El; Grifka, Ronald G

Fletcher, Jeffrey J; Feucht, Eric C; Hahn, Peter Y; McGoff, Theresa N; Dehart, Del J; Mortada, Mohamad E El; Grifka, Ronald G.

Fletcher JJ; Metro Health University of Michigan Health, Critical Care Medicine, Wyoming, Michigan.
Feucht EC; Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan.
Hahn PY; Metro Health University of Michigan Health, Critical Care Medicine, Wyoming, Michigan.
McGoff TN; Metro Health University of Michigan Health, Critical Care Medicine, Wyoming, Michigan.
Dehart DJ; Metro Health University of Michigan Health, Department of Research, Wyoming, Michigan.
Mortada MEE; Metro Health University of Michigan Health, Infectious Disease, Wyoming, Michigan.
Grifka RG; Metro Health University of Michigan Health, Infectious Disease, Wyoming, Michigan.

Infect Control Hosp Epidemiol ; 43(3): 407-409, 2022 03.

Article in English | MEDLINE | ID: covidwho-2000823

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral; COVID-19/epidemiology; Community Health Planning; Humans; Seroepidemiologic Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Infect Control Hosp Epidemiol Journal subject: Communicable Diseases / Nursing / Epidemiology / Hospitals Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google